E Nizankowska

Summary

Country: Sweden

Publications

  1. ncbi Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics
    B Dahlen
    Department of Medicine at Karolinska Hospital, Karolinska Institutet, Stockholm, Sweden
    Am J Respir Crit Care Med 157:1187-94. 1998

Detail Information

Publications1

  1. ncbi Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics
    B Dahlen
    Department of Medicine at Karolinska Hospital, Karolinska Institutet, Stockholm, Sweden
    Am J Respir Crit Care Med 157:1187-94. 1998
    ..The study also suggests that addition of a leukotriene pathway inhibitor such as zileuton may bring about greater control of asthma than what is achieved by treatment with medium to high doses of glucocorticosteroids alone...